Journal of Immunological Techniques & Infectious Diseases ISSN: 2329-9541

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Mausumi Bandyopadhyay Author

sdasgupta@mail.sjsm.org 1-264-497-5125 | 1-264-497-51

Subjects of specialization
Multiple sclerosis; CD52; Lymphocytes; Monoclonal antibody; Alemtuzumab

Affiliation
Biological Sciences, Trident Technical College, North Charleston, South Carolina 29406, USA

Biography

Dr. Mausumi Bandyopadhyay was an Assistant Professor of Biological Sciences, Trident Technical College, North Charleston, South Carolina 29406, USA and later he started his career in Prospect of CD52 Targeted Alemtuzumab in Treatment of CNS Demyelination in Multiple Sclerosis

Publications

Review Article Subscription

Prospect of CD52 Targeted Alemtuzumab in Treatment of CNS Demyelination in Multiple Sclerosis

Author(s):

Subhajit Dasgupta and Mausumi Bandyopadhyay

Prospect of CD52 Targeted Alemtuzumab in Treatment of CNS Demyelination in Multiple Sclerosis

The choice of humanized monoclonal antibody is a novel therapeutic approach for autoimmune relapsing remitting multiple sclerosis (RRMS). In addition to anti-alpha-4 integr in monoclonal antibody Natalizumab, introduction of CAMPATH-1 (Alemtuzumab) is a fairly new approach in MS research and clinical trials. The uniqueness of this monoclonal antibodyis that it d... view more»

DOI: 10.4172/2329-9541.1000131

Abstract HTML PDF

Social Media

Google Scholars / Researchers Sites

Explore SciTechnol

GET THE APP